Please assess the completion status of the following clinical trial:

Trial Title: PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years of age (no upper age limit)~* Signed, IRB-approved written informed consent~* Must have clinical T1-3, N0-3, M0 disease. All phenotypes are acceptable..~* Must have surgically curable disease as evaluated by the UNC Multidisciplinary Tumor Board.~* Must have pre- and post-treatment MRI imaging as part of the treatment plan.~* Must be able to meet size restrictions for the PET-MR scanner: chest depth and abdominal depth less than 27 cm (approximately the smallest 55% of women will meet this), as measured on imaging or with physical template.~* Must be in acceptable health to undergo chemotherapy and curative intent surgery as assessed by Multidisciplinary Tumor Board.~* Must be able to understand and comply with study procedures for the entire length of the study.~* Must receive their chemotherapy and curative intent surgery at UNC Hospitals. -If patient has a history of prior malignancy, including melanoma, patient must be cancer- free for three or more years. Non-melanoma skin cancers will be included even if not cancer-free for three years.~* Women of childbearing potential must have a negative serum or urine pregnancy test performed within 7 days prior to each PET/MRI~Exclusion Criteria:~* Inability to tolerate MRI (e.g., inability to lie flat for \>1 hour)~* Presence of pacemaker, intracranial aneurysm clip, bladder stimulator, cochlear implant or metal near eyes or near pelvis that would create excessive imaging artifact~* Poorly controlled diabetes mellitus~* Patient receiving neoadjuvant endocrine therapy (due to low likelihood of complete response)~* Pregnancy or lactating female~* Substance abuse, medical, psychological, or social conditions that may interfere with the patient's participation in the study~* Evidence of distant disease on physical exam or initial imaging~* Medical conditions precluding chemotherapy or curative intent surgery~* Incarcerated or otherwise institutionalized at time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PET/MR (Type: EXPERIMENTAL): Each patient will undergo two combined PET/MR scans. The pre-treatment and post-treatment combined PET/MR scans are for research purposes and not part of the patient's standard of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).